TrialInternational journal of colorectal disease2020

Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome.

Ravichandran Gayathri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.